OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
RIICI54

Rights and Issues Investment Trust PLC

UK Investment TrustsVerified

The company's capital structure is characterized by a lack of detailed liquidity metrics, as liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The shares outstanding for both basic and diluted scenarios are identical at 4.77 million, indicating no dilution risk from share issuance at this time. Profitability and returns data are not available in the current valuation snapshot, and no industry-specific preferred metrics are provided for comparison. As a UK investment trust, the company's performance is typically measured by total return and dividend yield, but these metrics are not disclosed in the current dataset. Segment and geographic exposure data are not disclosed in the available source documents, making it difficult to assess revenue concentration or geographic diversification. The company's growth trajectory is also unclear, as no outlook data or revenue history is provided in the current dataset. Risk factors include the inability to assess liquidity risk, which is a concern for investment trusts that rely on maintaining sufficient liquidity to meet redemption requests. The dilution risk is currently rated as low, with no evidence of dilution pressure from recent issuance or capital-raising activities. No recent events, such as filings or transcripts, are available in the current dataset to provide further insight into the company's operations or strategic direction.

30-day price · RIICI(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyRights and Issues Investment Trust PLC
TickerRIICI.L
SectorFinancials
BusinessCollective Investments
Industry groupCollective Investments
IndustryUK Investment Trusts
AI analysis

Business. Rights and Issues Investment Trust PLC is a UK-based investment trust that primarily invests in a diversified portfolio of equities, with a focus on income generation and capital appreciation.

Classification. The company is classified under the Financials sector, specifically within the Collective Investments business sector and the UK Investment Trusts industry, with a high confidence level of 0.92.

The company's capital structure is characterized by a lack of detailed liquidity metrics, as liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The shares outstanding for both basic and diluted scenarios are identical at 4.77 million, indicating no dilution risk from share issuance at this time. Profitability and returns data are not available in the current valuation snapshot, and no industry-specific preferred metrics are provided for comparison. As a UK investment trust, the company's performance is typically measured by total return and dividend yield, but these metrics are not disclosed in the current dataset. Segment and geographic exposure data are not disclosed in the available source documents, making it difficult to assess revenue concentration or geographic diversification. The company's growth trajectory is also unclear, as no outlook data or revenue history is provided in the current dataset. Risk factors include the inability to assess liquidity risk, which is a concern for investment trusts that rely on maintaining sufficient liquidity to meet redemption requests. The dilution risk is currently rated as low, with no evidence of dilution pressure from recent issuance or capital-raising activities. No recent events, such as filings or transcripts, are available in the current dataset to provide further insight into the company's operations or strategic direction.
Key takeaways
  • The company's liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents.
  • There is no evidence of dilution risk at this time, as basic and diluted shares outstanding are identical.
  • Profitability and returns data are not available, making it difficult to assess performance relative to industry benchmarks.
  • No segment or geographic exposure data is disclosed, limiting visibility into revenue concentration and diversification.
  • Growth trajectory and recent strategic developments are not available in the current dataset.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$61.9M$61.1M$60.4M
FY-3-$53.1M-$54.2M-$54.2M
FY-2$4.9M$3.6M$3.6M
FY-1$13.1M$11.8M$11.8M
FY0$5.9M$4.7M$4.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$223.8M$223.7M$26.8M
FY-3$141.0M$140.8M$6.0M
FY-2$131.6M$131.4M$1.1M
FY-1$123.6M$123.1M$1.9M
FY0$124.8M$124.5M$2.8M
PeriodOCFCapExFCFSBC
FY-4$21.3M
FY-3$8.0M
FY-2$8.0M
FY-1$20.7M
FY0$4.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: UK Investment Trusts · cohort 1 companies
MetricRIICIActivity
Op margin86.0% medp25 53.6% · p75 95.9%
Net margin84.2% medp25 47.0% · p75 95.4%
Gross margin90.3% medp25 73.4% · p75 97.4%
CapEx / revenue-0.1% medp25 -0.1% · p75 -0.1%
Debt / equity3.8% medp25 0.0% · p75 9.5%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 00:45 UTC#08f6cd1d
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 05:11 UTCJob: 6b7cf88d